Peptide library › Metabolic & weight
5-Amino-1MQ
Also known as 5-amino-1-methylquinolinium
Small molecule sold alongside peptides for fat loss; blocks the enzyme NNMT. Not a peptide, and untested in people.
What people use it for
- Fat loss and metabolism (marketed)
- Longevity and NAD+ support (marketed)
What 5-Amino-1MQ does in the body
Blocks NNMT, an enzyme that becomes more active in fat tissue in obesity. In cell studies this raises NAD+ and SAM, two molecules involved in energy use, and reduces fat building in fat cells. In obese mice it lowered body weight and fat without changing how much they ate.
Strength of evidence
Very limited: animal and cell studies only. No human trials have been published.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Unknown in humans: no safety studies have been done
- Unknown long-term effects on methylation, which NNMT is involved in
- Purity and dose of grey-market products are not checked
Who should avoid it or take extra care
- Pregnancy or breastfeeding, unless a specialist advises it
- Anyone with a history of cancer, since NNMT's role in cancer isn't understood
- Anyone taking prescription medicines, as interactions are unknown
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
Not approved by the FDA or any regulator for any use. Sold online as a research chemical.
How it's taken
Route: Usually taken by mouth as capsules (grey market)
How long it lasts (half-life): Not established in humans
Storage
Powder vials are usually kept refrigerated or frozen and away from light. Once mixed, keep refrigerated and follow the supplier's stated use-by date.
Keep track of 5-Amino-1MQ privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open 5-Amino-1MQ in Fiala How to installMore in Metabolic & weight
- SemaglutideOnce-weekly GLP-1 receptor agonist for type 2 diabetes and chronic weight management.
- TirzepatideOnce-weekly dual GIP and GLP-1 receptor agonist for type 2 diabetes and weight management.
- RetatrutideExperimental triple GIP / GLP-1 / glucagon receptor agonist being studied for obesity.
- AOD-9604Modified fragment of human growth hormone once developed as an anti-obesity drug.
- LiraglutideOnce-daily GLP-1 receptor agonist; the predecessor of semaglutide.
- CagrilintideLong-acting amylin analog being studied for weight loss, mainly combined with semaglutide.
- MazdutideOnce-weekly dual GLP-1 and glucagon receptor agonist for weight management.
- SurvodutideExperimental once-weekly dual glucagon and GLP-1 receptor agonist being studied for obesity and fatty liver disease.
- DulaglutideOnce-weekly GLP-1 receptor agonist approved for type 2 diabetes.
- ExenatideThe first GLP-1 receptor agonist, originally found in Gila monster venom, approved for type 2 diabetes.
- PramlintideSynthetic version of the hormone amylin, used with mealtime insulin in diabetes.
- SetmelanotideMC4R agonist approved for rare genetic causes of severe obesity.
- AlbiglutideOnce-weekly GLP-1 medicine for type 2 diabetes, discontinued for business reasons in 2018.
- AmycretinExperimental single molecule that acts on both GLP-1 and amylin receptors, tested as a weekly injection and a daily tablet for weight loss.
- EfpeglenatideLong-acting experimental GLP-1 medicine that cut heart and kidney events in people with type 2 diabetes in a large trial.
- LixisenatideOnce-daily GLP-1 medicine for type 2 diabetes, now mainly used in a combined pen with insulin glargine.
- PemvidutideExperimental weekly injection that acts on GLP-1 and glucagon receptors, studied for obesity and fatty liver disease.
- PetrelintideExperimental long-acting amylin analog given weekly for weight loss, aiming for fewer stomach side effects than GLP-1 drugs.
- Insulin analogsLab-modified versions of insulin that work faster or last longer, used to treat type 1 and type 2 diabetes.
- GlucagonEmergency hormone that quickly raises blood sugar during a severe hypo; also used to relax the gut during scans.
- DasiglucagonStable, ready-to-use version of glucagon for treating severe low blood sugar in people with diabetes.